Head-to-head comparison
Hims & Hers vs Renlo Health
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
Mass-market app-first program with nationwide polish — tirzepatide pricing disclosure lags the ranking.
$199/mo sema
Marked down on: Tirzepatide pricing inconsistently disclosed
FDAWarning letter issued to Hims & Hers Health, Inc. dba Hims in September 2025. See the FDA warning-letter database.
Desk Score
One of the few programs whose headline is the actual monthly rate, with the prescribing physician and the dispensing pharmacy both named.
$199/mo (see conditions) sema · $269/mo (see conditions) tirz · Verified September 2026
Marked down on: A struck-through $399 sits beside the price with no published basis — Renlo never says what it was, when it applied or to whom.
Renlo Health takes this head-to-head with the higher Desk Score, 80/100 (B−) against 79/100 (C+) for Hims & Hers. Hims & Hers still holds its ground where its strengths line up with yours.
Desk Score, dimension by dimension
Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.
Hims & Hers
79/100
C+
Renlo Health
80/100
B−
Price transparency
State access
Molecule range
Onboarding speed
Support responsiveness
Licensing & trust
The spec sheet
| Field | Hims & Hers | Renlo Health |
|---|---|---|
| Semaglutide | $199/mo$199/mo | $199/mosee conditions$199/mo (compounded, billed monthly at every dose) |
| Tirzepatide | Not listed on Hims & Hers's site | $269/mosee conditions$269/mo (compounded, billed monthly at every dose) |
| Coverage | All 50 states | Not listed on Renlo Health's site (checked September 2026) |
| Brand-name | Compounded only | Compounded only |
| Oral option | Injectable only | Injectable only |
| Best for | People who want a familiar consumer-brand app experience and don't need tirzepatide. | Someone who wants a flat monthly bill, a named prescriber and a refund route, and can ignore an anchor nobody explains. |
| Desk Score | 79/100C+ | 80/100B− |
The verdict
Desk pick — Renlo HealthRenlo Health takes this head-to-head with the higher Desk Score, 80/100 (B−) against 79/100 (C+) for Hims & Hers. Hims & Hers still holds its ground where its strengths line up with yours.
Choose Hims & Hers if…
People who want a familiar consumer-brand app experience and don't need tirzepatide.
$199/mo sema · All 50 states
FDAWarning letter issued to Hims & Hers Health, Inc. dba Hims in September 2025. See the FDA warning-letter database.
Choose Renlo Health if…
Someone who wants a flat monthly bill, a named prescriber and a refund route, and can ignore an anchor nobody explains.
$199/mo (see conditions) sema · $269/mo (see conditions) tirz
Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we write about a provider reads the same either way. Read full breakdowns: Hims & Hers · Renlo Health.
Also here
CoreAge Rx leads the whole ranking at 94/100
Whichever of these two you lean toward, our #1-rated provider outscores them both. One price at every dose, both molecules, all 50 states. The $99 and $149 figures are 12-month plans paid up front, not a monthly bill.
More head-to-heads
- CoreAge Rx vs Hims & Hers
- CoreAge Rx vs Renlo Health
- Hims & Hers vs Ondra Health
- HealthRX vs Renlo Health
- Hims & Hers vs Vaylen
- Renlo Health vs Welling Health
Or see the full comparison hub and the complete ranking.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.